Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 6.64 | 8,282 | 54.99 k | 355,082 |
2 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 18,950 | 0.00 | 363,364 |
2 Feb 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 18,950 | 0.00 | 18,950 |
1 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 6.64 | 7,231 | 48.01 k | 344,414 |
1 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 16,545 | 0.00 | 351,645 |
1 Feb 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 16,545 | 0.00 | 0 |
31 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Grant | Acquire A | No | No | 5.18 | 4,105 | 21.26 k | 335,100 |
30 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 7 | 11,701 | 81.91 k | 330,995 |
30 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 26,775 | 0.00 | 342,696 |
30 Jan 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 26,775 | 0.00 | 53,550 |